Indian pharmaceutical giant Aurobindo Pharma Limited expressed strong interest in establishing a manufacturing facility in the Philippines, following a meeting with the Philippine Economic Zone Authority (PEZA) on Sept. 26, 2024.
PEZA, in collaboration with the Food and Drug Administration (FDA), is enhancing its one-stop-shop services to attract pharmaceutical investments.
“Prompt issuance of FDA permits and the planned satellite laboratory demonstrate our commitment to growing the pharmaceutical sector,” said PEZA director-general...
Indian pharmaceutical giant Aurobindo Pharma Limited expressed strong interest in establishing a manufacturing facility in the Philippines, following a meeting with the Philippine Economic Zone Authority (PEZA) on Sept. 26, 2024.
PEZA, in collaboration with the Food and Drug Administration (FDA), is enhancing its one-stop-shop services to attract pharmaceutical investments.
“Prompt issuance of FDA permits and the planned satellite laboratory demonstrate our commitment to growing the pharmaceutical sector,” said PEZA director-general...
SB Capital Investment Corp., the investment banking arm of Security Bank Corp., signed separate service agreements with the Bank of Ayudhya (Krungsri) and MUFG...
Listed miner Omico Corp. said Thursday it cancelled its joint venture partnership with Sta. Lucia Realty and Development Inc. to develop a property in...
Solar Philippines Nueva Ecija Corp. said Thursday it raised P2.8 billion from its recently-concluded stock rights offering.
SPNEC said in a disclosure to the stock...